Aeternum Health (AETN) EBITDA Margin (2010 - 2026)

Aeternum Health (AETN) has reported EBITDA Margin for 11 consecutive years, with 5289.78% the latest figure, recorded in Q1 2026.

• On a quarterly basis, EBITDA Margin fell 530358.0% year-over-year to 5289.78% in Q1 2026; TTM through Mar 2026 was 997.52%, a 86360.0% decrease from a year earlier, with the FY2025 full-year figure at 132.22%, up 52884.0% from the prior year.
• EBITDA Margin was 5289.78% for Q1 2026 at Aeternum Health, down from 349.98% in the prior quarter.
• Over five years, EBITDA Margin peaked at 13.81% in Q1 2025 and troughed at 11134.79% in Q3 2023.
• A 5-year average of 1944.08% and a median of 961.58% in 2023 frame the typical range for EBITDA Margin.
• Across the five-year window, EBITDA Margin surged 115929 bps in 2022 and tumbled 1032519 bps in 2023, its largest moves.
• Over 5 years, EBITDA Margin stood at 598.13% in 2022, then plunged by 485 bps to 3500.46% in 2023, then surged by 72 bps to 991.7% in 2024, then jumped by 65 bps to 349.98% in 2025, then slumped by 1411 bps to 5289.78% in 2026.
• The last three EBITDA Margin figures came in at 5289.78% (Q1 2026), 349.98% (Q4 2025), and 1449.29% (Q3 2025), per Business Quant data.